|
The collaboration agreement is summarized as follows.
Syngenta and the collaborator have exclusive access to the data and
bioinformatics-analyzed results generated during the collaboration for the
first three months after Syngenta provides the initial results to the
collaborator. This will facilitate the effort by the two parties to get maximum
benefit from joint mining of the data.
Syngenta retains ownership of any data and other results generated by Syngenta
scientists. The collaborator retains ownership of any data and subsequent
research results generated by the collaborator.
After the exclusive period, the collaborator and Syngenta will work together to
publish and patent results from the collaboration. To avoid jeopardizing
intellectual property and its protection, the collaborator will provide
proposed publications (manuscripts, presentations, etc.) to Syngenta for
approval 60 days prior to submission for publication. Publications by either
party will acknowledge the other and include the other partys scientists as
co-authors as appropriate.
The collaborator will notify Syngenta of any inventions it makes as a result of
the collaboration. Syngenta will cover all patent costs for inventions of
interest to Syngenta.
The collaborator and Syngenta each get use of all results and IP from the
collaboration for research purposes.
Syngenta gets a first right to negotiate a commercial license to any new IP
solely owned by the collaborator. For jointly owned IP, Syngenta has the right
to use it non-exclusively for commercial purposes but also has an option to
negotiate an exclusive commercial license. Syngenta has a limited period of
time within which to notify the collaborator of its interest in obtaining a
license. For all commercial licenses for Syngenta, the parties will agree in
good faith on a reasonable financial return to the collaborators institution.
The GeneChip technology that Syngenta uses in these collaborations is from
Affymetrix, so the agreement includes some additional terms that are required
under SBIs separate agreement with Affymetrix.
Data release will follow
Syngenta Microarray Data Publication Guidelines.
|
